Order results by:
| Issue | Title | |
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... significant decrease in sPECAM-1 level (p<0.05). Thus, olmesartan + lercanidipine combination has more ..." | ||
| Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
| E. I. Emelina, G. E. Gendlin | ||
| "... Features and possibility of application of the calcium channel blocker lercanidipine in cardiology ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... . Lercanidipine is a dihydropyridine calcium channel blocker of the third generation with high lipophilicity ..." | ||
| Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
| "... on lercanidipine is justified. ..." | ||
| Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
| "... pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials ..." | ||
| Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| "... lercanidipine with ACE inhibitor enalapril are presented. ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... Цель. Оценить эффективность лерканидипина (антагониста кальция из группы дигидропиридинов) у ..." | ||
| Vol 12, No 6 (2016) | RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME | Abstract similar documents |
| O. M. Drapkina, J. S. Sibgatullina | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... and safety of the combination of calcium antagonist of the third generation, lercanidipine, and ACE inhibitor ..." | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..." | ||
| Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
| D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
| "... , lercanidipine hydrochloride daily. She was admitted to the hospital complaining of weakness, eyes darkening ..." | ||
| Vol 12, No 5 (2016) | Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva | ||
| "... ADRs. Other class III drugs should be prescribed to the elderly with great caution under close ..." | ||
| Vol 2, No 3 (2006) | COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS | Abstract similar documents |
| O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova | ||
| "... of procollagen type III was also estimated. Results. Enalapril versus atenolol improved blood rheology, reduced ..." | ||
| Vol 2, No 1 (2006) | SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) | Abstract similar documents |
| I. A. Latfullin, R. F. Gaifullina | ||
| "... Aim. To evaluate antiarhythmic efficiency of Nibentan (Verofarm, Russia), antiarrythmic drug III ..." | ||
| Vol 10, No 2 (2014) | REPORT ON III INTERNATIONAL FORUM OF CARDIOLOGY AND INTERNAL MEDICINE, MARCH 24-26, 2014, MOSCOW | Abstract similar documents |
| R. G. Oganov, M. N. Mamedov | ||
| Vol 11, No 1 (2015) | III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG | Abstract similar documents |
| Vol 11, No 2 (2015) | III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG | Abstract similar documents |
| Vol 15, No 6 (2019) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs | Abstract similar documents |
| D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova | ||
| Vol 7, No 4 (2011) | EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. I. Makhiyanova, A. S. Galyavich | ||
| "... Цель. Изучить эффективность и безопасность блокатора гликопротеиновых рецепторов IIb/IIIа ..." | ||
| Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
| "... (blebbing, desquamated endothelial cells, membrane-liberated parts, sPECAM-1). Results. Reduction in levels ..." | ||
| Vol 17, No 2 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| "... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..." | ||
| Vol 4, No 5 (2008) | EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS | Abstract similar documents |
| S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya | ||
| "... with chronic heart failure (CHF) class II-III suffering from giddiness. Material and methods. 61 patients ..." | ||
| Vol 17, No 5 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| "... Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon ..." | ||
| Vol 3, No 2 (2007) | THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS | Abstract similar documents |
| I. I. Sinitsina, V. A. Orlov, G. U. Zacharova, T. A. Gembitskaya | ||
| "... pectoris of II-III functional class (FC). Material and methods. 45 patients with II FC (31 persons ..." | ||
| Vol 7, No 5 (2011) | HEREDITARY INTRAVENTRICULAR CONDUCTION DISORDERS IN THE FAMILY FROM KRASNOYARSK | Abstract similar documents |
| A. A. Chernova, S. Yu. Nikulina, S. S. Tret'yakova, T. I. Ul'yanova | ||
| "... of intracardiac conduction disorders in grandson, niece, son of the proband niece, ie, in the III-degree relatives ..." | ||
| Vol 2, No 3 (2006) | HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. I. Markova, A. I. Radzevich | ||
| "... in patients with arterial hypertension (AH), stage II-III. Material and methods. 30 patients (10 men, 20 women ..." | ||
| Vol 9, No 3 (2013) | REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY | Abstract similar documents |
| A. A. Klimenko, N. A. Shostak, N. A. Demidova, I. V. Novikov, S. M. Sorokoletov, S. V. Madoyan | ||
| "... had pulmonary hypertension (PH) degree I, and 13 (16.5%) — PH degree II–III. Group of comparison con ..." | ||
| Vol 3, No 1 (2007) | CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA | Abstract similar documents |
| M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva | ||
| "... ,2% and physical activity tolerance – by 47,6%. Before treatment 32 CHF patients with IDA (51,6%) had III ..." | ||
| Vol 18, No 5 (2022) | Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, D. F. Nizamova | ||
| "... . Results. Patients with class II CHF were hyperexpression of IGF-1, with class III CHF were registered low ..." | ||
| Vol 13, No 6 (2017) | FUNCTIONAL STATE OF THE MICROCIRCULATION OF THE SKIN ACCORDING TO LASER DOPPLER FLOWMETRY IN PATIENTS WITH ATRIAL FIBRILLATION WHO UNDERWENT CARDIOEMBOLIC STROKE | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, A. A. Fedorovich, O. M. Drapkina | ||
| "... factor (vWF), tissue plasminogen activator inhibitor-1 (PAI-1), antithrombin III (AT III) and plasminogen ..." | ||
| Vol 6, No 6 (2010) | THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS | Abstract similar documents |
| O. V. Gaisenok | ||
| "... classification, diagnosis and treatment. Prospects of new anti-arrhythmic drugs class III, in particular ..." | ||
| Vol 9, No 2 (2013) | INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS | Abstract similar documents |
| Zh. M. Sizova | ||
| "... of the complex 12-week treatment in patients with angina II-III functional class, based on the original ..." | ||
| Vol 19, No 4 (2023) | Wellens’ syndrome in clinical practice | Abstract similar documents |
| K. G. Pereverzeva, N. V. Dubova, S. A. Biryukov, G. V. Nozhov, S. S. Yakushi | ||
| "... of patients with anginal pain. The first patient is 43-year-old with a diagnosis of class III exertional ..." | ||
| Vol 6, No 6 (2010) | NATIONAL AWARD IN CARDIOLOGY “PURPLE HEART” WILL BE BESTOWED TO THE BEST CARDIAC SURGEON | Abstract similar documents |
| "... говорилось 18 ноября 2010 года на пресс-конференции, посвященной старту III национальной Премии в области ..." | ||
| Vol 7, No 2 (2011) | PREDICTIVE ROLE OF CONNEXIN 40 IN THE PATHOGENESIS OF HEREDITARY SICK SINUS SYNDROME | Abstract similar documents |
| S. Yu. Nikulina, A. A. Chernova, V. A. Shulman, T. S. Kukushkina, M. I. Voevoda, V. N. Maksimov | ||
| "... . Probands were 20 women and 9 men (aged 58±0.15). Relatives, I-III degree of kinship, were 65 men and 68 ..." | ||
| Vol 9, No 1 (2013) | ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION | Abstract similar documents |
| A. N. Zakirova, E. R. Abdukova, N. E. Zakirova | ||
| "... with CHF class III–IV with AF was significantly higher than this in control group and patients with CHF ..." | ||
| Vol 10, No 4 (2014) | EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE | Abstract similar documents |
| I. I. Esenova, L. N. Lisenker | ||
| "... in patients with arterial hypertension (HT) III stage after stroke during therapy based on bisoprolol 5-10 mg ..." | ||
| Vol 5, No 1 (2009) | CHANGES OF INTERCELLULAR COOPERATION IN PERIPHERAL BLOOD IN TREATED PATIENTS WITH CARDIOLOGIC DISEASES | Abstract similar documents |
| L. N. Korichkina, V. S. Volkov | ||
| "... -III (50 untreated patients), 150 patients with IHD and 210 patients with CHF of stages I-III. All ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. I. Sinitsina, V. A. Orlov, G. J. Zaharova | ||
| "... heart disease (IHD). Material and methods. 41 patients with CHF class II-III (NYHA), which complicated ..." | ||
| Vol 17, No 1 (2021) | Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova, D. F. Nizamova | ||
| "... (77.2±6.33 ng/ml with class IV CHF versus 46.7±3.74 ng/ml and 58.9±4.75 ng/ml with class II and III ..." | ||
| Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
| I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.001), ST segment elevation in lead III (9 ..." | ||
| Vol 10, No 1 (2014) | ASSOCIATION BETWEEN HEART RATE VARIABILITY AND COMPONENTS OF THE METABOLIC SYNDROME IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... компонент МС) составили 113 женщин (39%), II группу (2-3 компонента МС) 109 женщин (37%), III группу (4-5 ..." | ||
| Vol 18, No 5 (2022) | The problem of obesity «through the eyes» of patients (results of the survey of patients of the outpatient registry) | Abstract similar documents |
| O. V. Lerman, Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina | ||
| "... .1%) with class I obesity, 42 (14.2%) with class II obesity, 21 (7.1%) with class III obesity. With an increase ..." | ||
| Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
| "... also suffering from heart failure II-III functional class (according to NYHA classification) and from ..." | ||
| Vol 18, No 1 (2022) | Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry | Abstract PDF (Eng) similar documents |
| D. Yu. Sedykh, A. I. German, O. N. Hryachkova, V. V. Kashtalap, O. L. Barbarash | ||
| "... .2% people with MI (I degree – 22.3%; II – 7.7%; III – 2.3%), lack of BMI at 0.5%, normal BMI at 20 ..." | ||
| Vol 17, No 3 (2021) | Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches | Abstract similar documents |
| A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov | ||
| "... : H2PEF and HFA-PEFF. Recently, a number of phase II and III randomized control trials have been ..." | ||
| Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
| A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
| "... for the prevention and treatment of tumor-associated VTE prior to phase III trials is not recommended. However ..." | ||
| Vol 3, No 1 (2007) | EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova | ||
| "... heart failure (CHF). Material and methods. 134 patients with CHF of I-III functional classes were ..." | ||
| Vol 3, No 4 (2007) | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE | Abstract similar documents |
| I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko | ||
| "... and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included ..." | ||
| Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
| "... and methods. 41 patients with HT of I-III grade were included into the study. A part of patients received ..." | ||
| Vol 4, No 2 (2008) | CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION | Abstract similar documents |
| S. Y. Nikulina, V. A. Schulman, O. O. Kuznetsova, N. V. Aksjutina, P. A. Shesternja, A. A. Chernova, V. N. Maksimov, I. V. Kulikov, S. N. Ustinov, Y. L. Kazarinova, A. G. Romashchenko, M. I. Voevoda | ||
| "... and their 301 relatives of I, II, III degrees (basic group) and 82 probands without heart diseases and their 163 ..." | ||
| Vol 13, No 1 (2017) | QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov | ||
| "... , n=23; 58±5.3 years old); and HT patients with chronic obstructive pulmonary disease (COPD; III group ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... degrees and MR of III-IV degrees were included into the study groups. Results: Patients in both groups ..." | ||
| Vol 3, No 2 (2007) | IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov | ||
| "... and angina pectoris of functional class (FC) II (30 patients), III (27 patients) and IV (26 patients ..." | ||
| Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
| "... . The real use of the DAT was assessed in part III on the basis of the multicenter study conducted ..." | ||
| Vol 8, No 5 (2012) | ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE | Abstract similar documents |
| M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina | ||
| "... including ivabradine. Material and methods. Patients (n=90) with CHF class II–III NYHA associated ..." | ||
| Vol 21, No 1 (2025) | Successful treatment of acute inflammatory cardiomyopathy in a young patient with COVID-19: a clinical case | Abstract similar documents |
| O. V. Soldatova, I. Ya. Goryanskaya | ||
| "... and clinical signs of pulmonary edema indicated acute left ventricular failure (Killip III). The background ..." | ||
| Vol 12, No 4 (2016) | New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) | Abstract similar documents |
| Article Editorial | ||
| "... данные клинического исследования III фазы ROCKET AF и международного проспективного исследования XANTUS ..." | ||
| Vol 6, No 5 (2010) | THE POLYMORPHISM OF Α2B-ADRENERGIC RECEPTOR GENE — A NEW GENETIC MARKER OF THE HEREDITARY SICK SINUS SYNDROME | Abstract similar documents |
| S. Iu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, M. I. Voevoda, V. N. Maksimov | ||
| "... – proband relatives of I, II and III degree (65 males and 68 females, 39±0.13 y.o.), group 3 (control) — 89 ..." | ||
| Vol 4, No 5 (2008) | EFFECT OF AMLODIPINE AND OF NIFEDIPINE RETARD ON AUTONOMIC REGULATION OF HEART RATE IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. D. Golovanova, T. V. Osipova | ||
| "... with ischemic heart disease and chronic heart failure, class I-III (NYHA), were examined. Biological age ..." | ||
| Vol 19, No 1 (2023) | Relief of persistent atypical atrial flutter: experience with the use of niferidil | Abstract similar documents |
| E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar | ||
| "... relevant. Thus, the use of a class III antiarrhythmic drug (niferidil) is of unconditional interest ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov | ||
| "... .66) as well as antegrade coronary blood flow through the infarct-related artery TIMI II-III in 61% and 67 ..." | ||
| Vol 13, No 4 (2017) | TAKOTSUBO SYNDROME AS ACUTE FORM OF MICROVASCULAR ANGINA. CLINICAL CASE | Abstract similar documents |
| S. A. Boldueva, M. V. Ryzhikova, N. S. Shvets, I. A. Leonova, I. Yu. Titova, I. N. Kochanov | ||
| "... myocardial infarction (elevation ST II, III, aVF, V2-6, positive troponin test). According to coronary ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... . Rivaroxaban can be given in fixed doses without routine coagulation control, and phase III studies and actual ..." | ||
| Vol 6, No 4 (2010) | MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev | ||
| "... with stable angina pectoris, II-III class (n=480) were involved into the study. Evaluation of the following ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY | Abstract similar documents |
| H. H. Shugushev, A. A. Gaeva | ||
| "... ) complicating ischemic heart disease (IHD). Material and methods. Patients (n=107) with CHF III-IV functional ..." | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... -III functional class and 18 healthy volunteers. Spontaneous and ADP-induced platelet aggregation were ..." | ||
| Vol 10, No 5 (2014) | DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY | Abstract similar documents |
| An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova | ||
| "... diabetes and ischemic heart disease and CHF class II-III (NYHA) were included into the study. Clinical ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... with stable angina of II-III functional classes received basic therapy included ASA (125 mg daily) to prevent ..." | ||
| Vol 5, No 1 (2009) | MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. N. Zakirova, R. G. Oganov, N. E. Zakirova, G. R. Klochkova, F. S. Musina | ||
| "... functional class (FC). 49 patients of G2 had angina of III FC, and 47 patients of G3 had angina of IV FC ..." | ||
| Vol 4, No 2 (2008) | INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE | Abstract similar documents |
| O. P. Dudarenko, E. L. Shkol’nik, , , | ||
| "... III - in 16 patients (29,1 %), class IV in 1 patient (1,8 %). Dynamics of life quality, severity ..." | ||
| Vol 4, No 4 (2008) | ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, R. G. Oganov, A. N. Zakirova, M. P. Plotnikova, G. M. Salakhova | ||
| "... - FC-III and 26 patients - FC-IV. The control group consisted of 25 healthy persons. Bicycle ergometry ..." | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| "... and methods. 20 patients with COPD II-III stage (GOLD 2006) in remission and HT 1-2 stage were involved ..." | ||
| Vol 17, No 4 (2021) | Medium-term Effects of Enhanced External Counterpulsation in the Structural and Functional Parameters of Blood Vessels in Patients with Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| K. S. Karaganov, O. A. Slepova, A. S. Lishuta, N. I. Solomakhina, Yu. N. Belenkov | ||
| "... (angina pectoris class II-III) complicated by chronic heart faillure class II-III (NYHA) were included ..." | ||
| Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
| S. V. Povetkin, Ju. V. Luneva | ||
| "... with the original drug in patients with stable angina. Material and methods. Patients with stable angina of II-III ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... losartan, 12,5 mg hydrochlorothiazide) in patients with arterial hypertension (AH) of I-III grade with high ..." | ||
| Vol 3, No 5 (2007) | EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| I. V. Vologdina | ||
| "... . Material and methods. 78 patients with CHF class III (NYHA) were involved in the study. Patients were 81 ..." | ||
| Vol 15, No 5 (2019) | Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris | Abstract similar documents |
| V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova | ||
| "... manifestations of angina of functional class II-III according to the Canadian classification) and an initial ..." | ||
| Vol 6, No 3 (2010) | BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS | Abstract similar documents |
| J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal | ||
| "... events and for cardiovascular events); III отчета группы экспертов по оценке и лечению ..." | ||
| Vol 8, No 2 (2012) | THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev | ||
| "... , 93 men and 27 women, with stable angina, functional class (FC) II (n=117, 97.5%) and III (n=3, 2 ..." | ||
| Vol 16, No 4 (2020) | The Use of Enhanced External Counterpulsation in the Treatment of Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Karaganov, A. S. Lishuta, Y. N. Belenkov | ||
| "... and methods. Patients (n=70) with verified stable CAD (angina pectoris class II-III) complicated by CHF class ..." | ||
| Vol 15, No 5 (2019) | Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... failure functional class (CHF FC) (I-II – 95.9%, III – 91.5%, IV – 69.6%); glomerular filtration rate (GFR ..." | ||
| Vol 19, No 5 (2023) | Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction | Abstract PDF (Eng) similar documents |
| T. H. Hoang, V. V. Maiskov, I. A. Merai, A. F. Safarova, Z. D. Kobalava | ||
| "... . Grade III was more frequent in T2MI in comparison with T1MI (14.9% vs 1.1%, p=0.001, respectively ..." | ||
| Vol 18, No 4 (2022) | Respiratory Muscle Strength in Patients with Coronary Heart Disease and Different Musculoskeletal Disorders | Abstract PDF (Eng) similar documents |
| E. D. Bazdyrev, N. A. Terentyeva, N. A. Galimova, K. E. Krivoshapova, O. L. Barbarash | ||
| "... .2%) patients with osteopenia, group III included 25 (6.5%) patients with osteosarcopenia, group IV included 282 ..." | ||
| Vol 18, No 3 (2022) | Acute Kidney Injury after Transcatheter Aortic Valve Implantation | Abstract similar documents |
| L. V. Kremneva, L. I. Gapon, S. V. Shalaev, D. V. Krasheninin | ||
| "... %, NYHA class III – 46%, NYHA class IV – 2%. The risk of operational mortality according to EuroSCORE II ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| "... class III to II increased in the sacubitril/valsartan group (p<0.05). Also, in this group, the effective ..." | ||
| Vol 12, No 5 (2016) | Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure | Abstract similar documents |
| A. A. Petrukhina, S. N. Tereshchenko, I. V. Zhirov | ||
| "... duration. All patients were II and III functional class (by NYHA). The studies analyzed the changes in NYHA ..." | ||
| Vol 12, No 6 (2016) | CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE | Abstract similar documents |
| E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto | ||
| "... ); the proportion of men – 44%. 95% of patients had HF IIIV (NYHA), among them 24% HF II, 61% HF III, 15% HF IV ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... RA [high frequency III/IV radiographic stage, high levels of IgM rheumatoid factor (RF), anti-cyclic ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... ,8 y.o.) with ischemic heart disease (IHD) (which was presented by angina pectoris, class I-III ..." | ||
| Vol 7, No 5 (2011) | PSYCHOMETRIC VISUAL ANALOGUE SCALE IN ASSESSMENT OF THE STABLE ANGINA SEVERITY AND EFFICACY OF ANTIANGINAL THERAPY | Abstract similar documents |
| E. V. Solyanik | ||
| "... III. Integral QL index lower than 3.8 only hypothetically could correspond to angina pectoris FC IV ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... (FC) III-IV than in those with CHF of FC I-II (p<0.001). Negative correlation was revealed between TrI ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... .001), III-IV degree mitral regurgitation (p=0.007), hyperuricemia (p<0.001), lower exercise tolerance (p=0 ..." | ||
| Vol 11, No 1 (2015) | METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 patients with HT stage II-III ..." | ||
| Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
| "... at the II and III stages of the trials were found to be unsuccessful due to the unacceptably high frequency ..." | ||
| Vol 3, No 2 (2007) | CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) | Abstract similar documents |
| V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin | ||
| "... on treatment in 1989, group II - 475 patients of 1993, and group III – 531 patients of 2003. There were ..." | ||
| Vol 5, No 1 (2009) | ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? | Abstract similar documents |
| T. A. Kazakovtseva, N. A. Shostak | ||
| "... level in severe CHF (III-IV class) and its rare increase in mild CHF (I-II class) were detected ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... with obesity II-III degrees as well as dyslipidemia the EEC values were significantly lower vs control group (p ..." | ||
| 1 - 100 of 139 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
